Editas Medicine Inc (EDIT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EDIT Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Editas Medicine Inc's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent181.82
Marketable Securities, Current SH29.83
Cash & Short-term Investments210.00
Accounts receivable2.73
Prepaid Expense And Other Assets Current3.70
Total Current Assets218.07
Equipment/Property/Plant Net29.27
Other Assets, Noncurrent0.00
Total Assets237.36
Liabilities
Accounts Payable, Current AC4.74
Accrued Liabilities, Current AC17.37
Long-term Debt, Current Maturities LO7.50
Other Liabilities, Current38.83
Total Current Liabilities68.43
Long-term debt48.24
Total Long-term Debt48.24
Other liabilities, Noncurrent15.41
Contract With Customer Liability Noncurrent44.51
Contract With Customer Liability Current-
Total Liabilities132.08
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,776.99
Retained Earnings / Accumulated Deficit-1,671.72
Accumulated Other Comprehensive Income-0.01
Other Equity-0.01
Common Stockholder's Equity105.28
Total Stockholder's Equity105.28
Liabilities & Stockholder's Equity237.36
4 historic quarters locked

Sign in to unlock the full Editas Medicine Inc balance sheet history.

About Editas Medicine Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001650664-26-000083

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.